MIRAGEN THERAPEUTICS, INC. (53) | Intellectual Property (3)

Browse by Subcategory

License Agreements (3)

Recent Contracts

Technology License Agreement, by and between the Registrant and Xencor, Inc., dated as of December 16, 2020 (Filed With SEC on March 26, 2021)
License Agreement, by and between the Company and ImmunoGen, dated as of October 12, 2020 (Filed With SEC on December 9, 2020)
Amendment No. 1 to Amended and Restated License Agreement, effective as of August 8, 2019, by and between Registrant and Roche Innovation Center Copenhagen A/S (Filed With SEC on November 8, 2019)